<http://webisa.webdatacommons.org/398025711>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/398025711>	<http://www.w3.org/ns/prov#value>	"?, of the antibodies of the invention comprise a portion of an intact antibody, generally including the antigen binding or variable region of the intact antibody or the Fc region of an antibody which retains FcR binding capability." .
<http://webisa.webdatacommons.org/prov/441197617>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/398025711> .
<http://webisa.webdatacommons.org/398025711>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com.au> .